Novelix Pharmaceuticals Ltd (NOVELIX) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Novelix Pharmaceuticals Ltd reported sales of ₹1.24 Cr, operating profit of ₹-0.19 Cr (OPM -15.32%) and net profit of ₹-0.15 Cr for the quarter ended Sep 2022. Figures in ₹ crore, consolidated where available.
NOVELIX quarterly results (₹ Cr) Metric Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Sales 2.19 2.51 4.35 2.46 1.11 0.69 1.36 1.24 Expenses 2.44 5.79 4.52 2.31 2.08 2.33 1.5 1.43 Operating Profit -0.25 -3.28 -0.17 0.15 -0.97 -1.64 -0.14 -0.19 OPM -11.42% -130.68% -3.91% 6.1% -87.39% -237.68% -10.29% -15.32% Other Income 0.11 0.05 0.17 0.32 0.07 0.13 0.07 0.06 Interest 0.01 0.01 0 0 0 0 0 0 Depreciation 0.08 0.06 0.05 0.04 0.04 -0.03 0.02 0.02 Profit before tax -0.23 -3.3 -0.05 0.43 -0.94 -1.48 -0.09 -0.15 Tax 0% 0% 60% 20.93% -22.34% 6.08% 0% 0% Net Profit -0.23 -3.29 -0.08 0.35 -0.73 -1.57 -0.09 -0.15 EPS in Rs -0.26 -4.05 -0.19 0.4 -0.77 -1.67 -0.09 -0.16
NOVELIX profit & loss, annual (₹ Cr) Metric Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM Sales 10.51 10.73 10.85 9.59 8.91 4.4 Expenses 10.47 10.62 10.75 13.06 11.1 7.34 Operating Profit 0.04 0.11 0.1 -3.47 -2.19 -2.94 OPM 0.38% 1.03% 0.92% -36.18% -24.58% -66.82% Other Income 0.15 0.11 0 0 0.32 0.33 Interest 0.16 0.13 0.12 0.07 0.06 0 Depreciation 0.24 0.21 0.19 0.21 0.1 0.05 Profit before tax -0.21 -0.12 -0.21 -3.75 -2.03 -2.66 Tax 66.67% 25% 23.81% 0.27% -0.49% - Net Profit -0.35 -0.15 -0.26 -3.76 -2.03 -2.54 EPS in Rs -0.43 -0.3 -0.35 -4.62 -2.22 -2.69 Dividend Payout 0% 0% 0% 0% 0% -
NOVELIX balance sheet (₹ Cr) Metric Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022 Equity Capital 8.1 8.1 8.1 8.1 8.1 Reserves 2.82 2.5 -1.24 -0.7 -0.9 Borrowings 0.93 0.77 0 0.16 1.02 Other Liabilities 1.49 2.35 2.72 1.18 0.23 Total Liabilities 13.34 13.72 9.58 8.74 8.45 Fixed Assets 1.92 1.83 1.65 2.2 2.17 CWIP 0 0 0 0 0 Investments 0.49 0.3 0.39 0.42 0.42 Other Assets 10.93 11.59 7.54 6.12 5.86 Total Assets 13.34 13.72 9.58 8.74 8.45
NOVELIX cash flows (₹ Cr) Metric Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Cash from Operating Activity 0.37 -0.53 0.63 1.59 1.59 Cash from Investing Activity -0.64 0.43 0.45 0.14 -0.76 Cash from Financing Activity 0.02 -0.05 -0.16 -0.77 0 Net Cash Flow -0.24 -0.15 0.92 0.96 0.83 Free Cash Flow 0.02 -0.38 0.52 1.56 -0.21 CFO/OP 925% -482% 630% -46% -73%
NOVELIX ratios Metric Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Debtor Days 75.36 111.92 44.07 52.52 50.39 Inventory Days 42.65 38.29 43.94 48.42 43.87 Days Payable 39.67 39.26 79.66 111.95 38.61 Cash Conversion Cycle 78.34 110.95 8.34 -11 55.65 Working Capital Days 321.59 324.18 284.6 116.85 87.67 ROCE -0.08% -0.8% -0.74% -38.23% -25.67%